Steven Cohen’s Teva Pharmaceutical Industries TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1,059,778
Closed -$37.9M – 4545
2026
Q2
$35.9M Sell
1,059,778
-70,729
-6% -$2.36M 0.04% 580
2026
Q1
$34.1M Buy
+1,130,507
New +$36.4M 0.04% 544
2024
Q4
– Sell
-517,712
Closed -$9.42M – 2442
2024
Q3
$9.33M Sell
517,712
-801,505
-61% -$14M 0.02% 667
2024
Q2
$21.4M Buy
1,319,217
+363,217
+38% +$5.59M 0.06% 384
2024
Q1
$13.5M Sell
956,000
-558,006
-37% -$7.03M 0.03% 606
2023
Q4
$15.8M Sell
1,514,006
-117,191
-7% -$1.09M 0.04% 524
2023
Q3
$16.6M Buy
1,631,197
+689,739
+73% +$6.42M 0.05% 459
2023
Q2
$7.09M Buy
941,458
+941,399
+1,595,592% +$7.63M 0.02% 692
2023
Q1
$522 Buy
+59
New +$583 ﹤0.01% 2139
2022
Q3
– Sell
-6,653,979
Closed -$58.8M – 1728
2022
Q2
$50M Buy
6,653,979
+5,424,079
+441% +$47.3M 0.21% 122
2022
Q1
$11.5M Buy
+1,229,900
New +$10.3M 0.05% 470
2021
Q2
– Sell
-1,568,700
Closed -$18.1M – 1162
2021
Q1
$18.1M Buy
+1,568,700
New +$18M 0.08% 285
2020
Q4
– Sell
-180,714
Closed -$1.63M – 1131
2020
Q3
$1.63M Buy
+180,714
New +$1.91M 0.01% 726
2019
Q4
– Sell
-27,409
Closed -$189K – 1241
2019
Q3
$189K Buy
27,409
+14,519
+113% +$111K ﹤0.01% 918
2019
Q2
$119K Buy
12,890
+9,698
+304% +$117K ﹤0.01% 1027
2019
Q1
$50K Buy
+3,192
New +$56.3K ﹤0.01% 969
2018
Q4
– Sell
-414,100
Closed -$8.92M – 1199
2018
Q3
$8.92M Sell
414,100
-3,317,214
-89% -$77M 0.04% 484
2018
Q2
$90.7M Buy
+3,731,314
New +$76.1M 0.36% 66
2018
Q1
– Sell
-327,650
Closed -$6.21M – 1121
2017
Q4
$6.21M Buy
327,650
+202,650
+162% +$3.05M 0.03% 549
2017
Q3
$2.2M Buy
+125,000
New +$2.81M 0.01% 668
2016
Q1
– Sell
-28,300
Closed -$1.86M – 844
2015
Q4
$1.86M Sell
28,300
-345,500
-92% -$21.4M 0.02% 556
2015
Q3
$21.1M Buy
373,800
+194,300
+108% +$12.6M 0.17% 185
2015
Q2
$10.6M Buy
179,500
+88,500
+97% +$5.46M 0.07% 309
2015
Q1
$5.67M Sell
91,000
-147,000
-62% -$8.55M 0.04% 420
2014
Q4
$13.7M Buy
238,000
+178,800
+302% +$10M 0.1% 272
2014
Q3
$3.18M Sell
59,200
-961,500
-94% -$50.9M 0.02% 456
2014
Q2
$53.5M Buy
+1,020,700
New +$52.2M 0.34% 77

Other funds holding TEVA

Steven Cohen's TEVA Position: Q3 2026 in Review

Steven Cohen sold out of Teva Pharmaceutical Industries (TEVA) in Q3 2026, closing a stake of 1,059,778 shares — an estimated $37.9M sold.

Steven Cohen first reported a position in TEVA in Q2 2014 and held it in 27 quarters. The position peaked at $90.7M in Q2 2018. 600 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

  • Steven Cohen reported no remaining Teva Pharmaceutical Industries position as of Q3 2026 after selling out during the quarter.
  • Steven Cohen sold 1,059,778 Teva Pharmaceutical Industries shares in Q3 2026, an estimated $37.9M.
  • Steven Cohen first reported a position in Teva Pharmaceutical Industries in Q2 2014 and held it in 27 quarters.
  • Steven Cohen's Teva Pharmaceutical Industries position peaked at $90.7M in Q2 2018.
  • 600 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.